Skip to content

Radiomics-Based Prediction of Meningioma Consistency

Radiomics-Based Prediction of Meningioma Consistency

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101520
Enrollment
Unknown
Registered
2025-04-25
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosed as meningioma by pathology

Interventions

Trial group:NA

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. No gender restriction; age >=18 years; 2. Pathologically confirmed brain tumor meeting the 2016 WHO diagnostic criteria, with documented WHO grade and subtype; 3. Preoperative brain MRI performed (non-contrast and contrast-enhanced), with MRI completed <=2 weeks before surgery; 4. Complete clinical records and imaging data of diagnostic quality;

Exclusion criteria

Exclusion criteria: 1. Prior radiotherapy, chemotherapy, or other treatments before MRI; 2. Incomplete clinical/surgical records or poor-quality imaging affecting diagnosis; 3. Lesion size too small (<3 visible imaging slices); 4. Lack of postoperative follow-up data;

Design outcomes

Primary

MeasureTime frame
Tumor consistency;

Secondary

MeasureTime frame
Patient surgery time;Intraoperative bleeding volume;Postoperative complications;

Countries

China

Contacts

Public ContactXiang Liu

Yuebei People’s Hospital

liuxiangxl72@163.com+86 751 6913416

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026